“kevin-starr” Archives

in
Entry Author Date Location
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
See Boston’s Newest Innovators & Influencers this Wed. at INFLUX 06/20/16 Boston
A Few Tickets Still Remain for Influx—Register Today for June 22 06/13/16 Boston
Autodesk, EMC, Project 11 Join Influx Program on June 22 06/09/16 Boston
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
Third Rock, SR One Put $52M Into Decibel to Battle Hearing Loss 10/15/15 Boston
Starr Out, Tessier-Lavigne in as Agios Chairman 06/23/15 Boston
Boston’s Life Science Disruptors: The Photos 10/21/14 Boston
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
One Week to Boston’s Life Science Disruptors—Check Out the Agenda 10/01/14 Boston
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Join Us For “Boston’s Life Science Disruptors” on Oct. 8 08/21/14 Boston
Sage Therapeutics Nabs $20M Series B From Third Rock, Arch 10/16/13 Boston
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Sage Taps Former Shire Exec to Lead CNS Drugs Into Clinical Trials 08/14/13 Boston
Dunsire Returns to Action to Tackle CNS Disorders With EnVivo 07/11/13 Boston
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Sage Therapeutics Shifts Gears, Focuses on Rare Form of Epilepsy 04/17/13 Boston
Still Waiting for the Ships to Come in at Third Rock Ventures 03/28/13 San Diego
Q&A With Bob Tepper on What’s Next for Third Rock Ventures 03/26/13 Boston
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
Theraclone’s Cliff Stocks Joins “Reinventing Biotech” Lineup Apr. 3 03/27/12 Seattle
Reinventing Biotech: Meet Corey Goodman, Kevin Starr & More April 3 02/23/12 Seattle
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3 01/19/12 Seattle
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases 10/18/11 Boston
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage 10/11/11 Boston
The Missing Ingredient in Today’s Biotech: Guts 07/11/11 National
Page 1 of 2 next page »